Skip to content
LexBuild

National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2011-27868"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2011-27868"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2011-10-27"
last_updated: "2011-10-27"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-27868"
document_type: "notice"
publication_date: "2011-10-27"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "76 FR 66732"
fr_volume: 76
---

#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee, November 9, 2011, 9 a.m. to November 9, 2011, 4 p.m., National Institutes of Health, Building 31, C-wing, 6th Floor, 31 Center Drive, Conference Room 10, Bethesda, MD 20892 which was published in the *Federal Register* on August 24, 2011, 76FR52960.

This notice is amended to add the Clinical Trials Network Strategic Planning ad hoc Subcommittee meeting on November 8, 2011 from 7 p.m. to 9 p.m. at the Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Ave., Bethesda, MD. The meeting is open to the public.

Dated: October 21, 2011.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.